OM Outset Medical, Inc.

NASDAQ
$3.15

Outset Medical, Inc. (OM) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with OM's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
23 transactions
Purchases
$0
0 shares
Sales
$369.2K
79,958 shares
Net activity
-$369.2K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $369.2K 23 transactions · 79,958 shares

Largest single sale: $87.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Gaeta Renee Chief Financial Officer Sell 4,543 $4.39 $19.9K 180,840 −2.5% of holding
Trigg Leslie Chair and CEO Sell 3,437 $4.39 $15.1K 194,597 −1.7% of holding
Brottem John L. General Counsel Sell 2,632 $4.39 $11.6K 87,475 −2.9% of holding
Gaeta Renee Chief Financial Officer Sell 17,672 $4.94 $87.3K 113,753 −13.4% of holding
Trigg Leslie Chair and CEO Sell 3,445 $3.70 $12.7K 98,874 −3.4% of holding
Brottem John L. General Counsel Sell 2,638 $3.70 $9.8K 30,277 −8% of holding
Nash Marc EVP Operations R&D & Service Sell 1,582 $3.70 $5.9K 38,393 −4% of holding
Trigg Leslie Chair and CEO Sell 3,361 $3.35 $11.3K 102,342 −3.2% of holding
Brottem John L. General Counsel Sell 2,842 $3.35 $9.5K 32,935 −7.9% of holding
Nash Marc EVP Operations R&D & Service Sell 1,817 $3.35 $6.1K 39,988 −4.3% of holding
Trigg Leslie Chair and CEO Sell 2,120 $5.05 $10.7K 105,703 −2% of holding
Brottem John L. General Counsel Sell 1,180 $5.01 $5.9K 35,777 −3.2% of holding
Nash Marc EVP Operations R&D & Service Sell 980 $4.98 $4.9K 41,805 −2.3% of holding
Trigg Leslie Chair and CEO Sell 11,794 $5.12 $60.4K 107,823 −9.9% of holding
Brottem John L. General Counsel Sell 9,314 $5.12 $47.7K 36,957 −20.1% of holding
Nash Marc EVP Operations R&D & Service Sell 5,375 $5.12 $27.5K 42,785 −11.2% of holding
Trigg Leslie Chair and CEO Sell 1,795 $4.27 $7.7K 119,617 −1.5% of holding
Brottem John L. General Counsel Sell 224 $4.27 $956 46,271 −0.5% of holding
Nash Marc EVP Operations R&D & Service Sell 108 $4.27 $461 48,160 −0.2% of holding
Drexler Karen Director Sell 1,548 $4.37 $6.8K 10,650 −12.7% of holding
Trigg Leslie Chair and CEO Sell 916 $4.60 $4.2K 121,412 −0.7% of holding
Brottem John L. General Counsel Sell 388 $4.60 $1.8K 46,495 −0.8% of holding
Nash Marc EVP Operations R&D & Service Sell 247 $4.60 $1.1K 48,268 −0.5% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.